PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials

PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials

Abstract Immune checkpoint inhibitors, especially the programmed cell death receptor-1/ligand 1 (PD-1/L1) inhibitors, displayed promising efficacy in several solid tumor types and hematological malignancies. Data related to their activity in soft-tissue sarcomas (STS) are scarce. We performed a pool...

Full description

Bibliographic Details
Main Authors: Antoine Italiano, Carine Bellera, Sandra D’Angelo
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Journal of Hematology & Oncology
Subjects:
Sarcoma
Immunotherapy
Pooled analysis
Online Access:http://link.springer.com/article/10.1186/s13045-020-00891-5

Similar Items

Similar Items